Alkermes’ Corporate Presentation to Be Webcast at Lazard Capital Markets Fifth Annual Healthcare Conference

Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Lazard Capital Markets on Tuesday, November 18, 2008 at 3:40 p.m. EST. The presentation will be webcast from the St. Regis Hotel in New York and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.

Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients’ lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes’ robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.